GRAP2: A Protein Involved in Cell Signaling and Growth (G9402)

Target Name: GRAP2

NCBI ID: G9402

GRAP2

GRAP2: A Protein Involved in Cell Signaling and Growth

Growth factor receptor-binding protein (GRAP2) is a protein that plays a crucial role in cell signaling and growth. It is a transmembrane protein that is composed of four extracellular domains and an intracellular domain. GRAP2 is a member of the TYRO3 family of G protein-coupled receptors (GPCRs), which are a subfamily of the large superfamily of GPCRs. GPCRs are involved in a wide range of cellular processes, including cell signaling, adhesion, and intracellular signaling.

GRAP2 is involved in many different cellular processes, including cell signaling, cell migration, and cell survival. It is a negative regulator of the TGF-β pathway, which is a well-known pathway involved in cell signaling and growth. The TGF-β pathway is a complex signaling pathway that is involved in many different cellular processes, including cell growth, differentiation, and inflammation.

GRAP2 is involved in the regulation of several different signaling pathways, including the TGF-β pathway, the ERK pathway, and the PI3K/AKT pathway. It is a negative regulator of the TGF-β pathway, which means that it promotes the inhibition of TGF-β signaling. This is important for maintaining cellular homeostasis and for the regulation of cellular processes such as cell signaling and cell survival.

GRAP2 is also involved in the regulation of cell migration and cell survival. It is a critical regulator of the decision to move or stay in place, as well as the ability to survive in different environments. GRAP2 plays a role in the regulation of cell adhesion, which is the process by which cells stick together and form tissues. It is also involved in the regulation of cell survival, as it promotes the survival of certain cell types when they are faced with stress or damage.

GRAP2 is a protein that is being targeted as a potential drug target. Its involvement in multiple cellular processes makes it an attractive target for researchers to study. For example, it is being investigated as a potential therapeutic agent for a variety of diseases, including cancer, neurodegenerative diseases, and autoimmune diseases.

GRAP2 is also being studied as a potential biomarker for a variety of diseases. Its involvement in multiple cellular processes makes it an attractive target for researchers to study. For example, it is being investigated as a potential biomarker for cancer, neurodegenerative diseases, and autoimmune diseases.

In conclusion, GRAP2 is a protein that plays a crucial role in cell signaling and growth. It is a member of the TYRO3 family of GPCRs and is involved in the regulation of multiple cellular processes, including cell signaling, cell migration, and cell survival. As a result, it is an attractive target for researchers to study and potential drug and biomarker targets. Further research is needed to fully understand the role of GRAP2 in cellular processes and its potential as a drug and biomarker.

Protein Name: GRB2 Related Adaptor Protein 2

Functions: Interacts with SLP-76 to regulate NF-AT activation. Binds to tyrosine-phosphorylated shc

The "GRAP2 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about GRAP2 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets